Press Release for Financial Results ended quarter Sep-25
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Deccan Health Care Ltd reported strong results for Q2 and H1 FY 2025-26 (quarter ended 30 September 2025). Standalone revenue from operations rose 29.7% YoY to ₹2,440.46 lakh in Q2, with H1 revenue up 35.4% YoY at ₹4,587.41 lakh. Standalone net profit jumped 67.5% YoY to ₹89.97 lakh in Q2 (H1 PAT up 22.8% YoY at ₹111.22 lakh). Consolidated Q2 PAT stood at ₹91.40 lakh and H1 PAT at ₹115.11 lakh. The company highlighted new wellness launches (EnergyDecc, SlimDecc, Reactive Go Advanced, fruit bars, gummies) and a new Weight Wellness Program, along with regulatory filings completed in six international markets and planned UAE/GCC launches by March 2026. EPS is improving and the company reported zero investor complaints.
Positive near-term sentiment is likely given strong top-line and bottom-line growth, improving margins, and new product expansion. Shareholders may view the international expansion plan and innovation-driven growth as supportive of long-term value creation, though standalone PAT growth far outpaces consolidated, indicating subsidiaries are still scaling.